Outreach Sequence Generator

Outreach Sequence Generator

Purpose

Generate a personalized, multi-touch outreach sequence for a specific prospect or company. Every touch must be genuinely personalized -- not templated mail-merge content. The tone is consultative and value-first, positioning Talosix as a thought partner rather than a vendor pitching features.

Workflow

Step 1: Gather Prospect Intelligence

Before writing any outreach, collect the necessary context:

1. Check for existing dossier: Search the local workspace for any prior prospect research.

   • Use Glob to find files matching *[company-name]* or *[prospect-name]* in the workspace.
   • Read any existing research files.

2. If no dossier exists, use WebSearch to quickly gather:

   • Company overview and recent news
   • Prospect's role, tenure, and background
   • Company's clinical trial pipeline (ClinicalTrials.gov)
   • Current EDC/technology stack if discoverable
   • Recent LinkedIn activity or conference appearances
   • Any published content (articles, podcast appearances, presentations)

3. Identify personalization anchors -- specific, verifiable facts that prove this outreach was crafted for them:

   • A specific trial they registered recently
   • A conference talk they gave
   • A blog post or article they published
   • A company milestone (funding, acquisition, new indication)
   • A regulatory event (FDA approval, submission)
   • A job posting that reveals internal priorities
   • A mutual connection or shared experience

Step 2: Define the Narrative Arc

Every sequence tells a story across touches. Define:

• Core insight: One observation about their business that demonstrates understanding (not a product pitch).
• Pain hypothesis: The specific operational challenge they likely face, based on research.
• Value bridge: How Talosix's approach (not features) addresses the pain.
• Social proof angle: A relevant peer company or industry trend that validates the approach.
• Call to action progression: From soft (share a resource) to medium (brief conversation) to direct (meeting request).

Step 3: Map Clinical Trial Pain Points

Select 2-3 pain points most relevant to this prospect based on their profile:

Step 4: Generate the Sequence

Create a 5-7 touch sequence following this cadence:

Touch 1: Initial Email (Day 1)

Purpose: Open the conversation with insight, not a pitch. Demonstrate you understand their world.

Structure:

• Subject line (2 A/B variants, under 50 characters, no spam triggers)
• Opening line: Reference a specific, recent event about them or their company (NOT "I hope this email finds you well")
• Insight paragraph: Share an observation about a challenge in their space that connects to their situation
• Bridge: One sentence connecting the insight to how companies like theirs are solving it
• Soft CTA: Offer a resource, perspective, or brief exchange -- not a demo request
• Signature: Keep it clean, include a relevant credential or social proof element

Rules:

• Under 150 words total
• No feature lists
• No "we" in the first two sentences
• First sentence must be about THEM, not Talosix
• Subject line must be specific enough that it could only apply to this prospect

Touch 2: LinkedIn Connection Request (Day 3)

Purpose: Open a second channel. The connection note should feel natural, not salesy.

Structure:

• Connection note (under 300 characters for LinkedIn limit)
• Reference a shared interest, mutual connection, or specific content they posted
• Do NOT pitch Talosix in the connection request
• If possible, reference the email ("I also sent a note about [topic]")

Touch 3: Email Follow-Up (Day 5)

Purpose: Add value, not pressure. Share something genuinely useful.

Structure:

• Subject line: Reply to original thread (Re: [original subject]) OR new angle (2 variants)
• Opening: Brief, acknowledge they're busy, no guilt-tripping
• Value add: Share a specific resource -- industry benchmark, regulatory update, case study, or insight relevant to their therapeutic area or trial phase
• Bridge: One sentence connecting the resource to a challenge they likely face
• CTA: Slightly more direct -- "Would a 15-minute conversation on [specific topic] be useful?"

Rules:

• Under 120 words
• The resource or insight must be genuinely valuable even if they never respond
• Do not repeat the same messaging from Touch 1

Touch 4: Value Share via LinkedIn or Email (Day 8)

Purpose: Demonstrate expertise. Position Talosix team as thought leaders.

Structure:

• If connected on LinkedIn: Send a message sharing a relevant article, report, or perspective
• If not connected: Send via email
• Content options:
  • A relevant industry report or benchmark (clinical trial timelines, data quality metrics)
  • A perspective on a regulatory change that affects their operations
  • A case study from a similar company (anonymized if needed)
  • Commentary on a trend in their therapeutic area
• Brief note (3-4 sentences) explaining why you thought of them specifically
• No CTA or a very soft one ("Thought this might be relevant to what you're working on")

Touch 5: Direct Email (Day 12)

Purpose: Make a clear, respectful ask. This is the "meeting request" touch.

Structure:

• Subject line: New thread, direct and specific (2 variants)
• Opening: Reference the value you've shared, acknowledge the outreach
• Hypothesis: State your hypothesis about a challenge they face (based on research)
• Offer: Propose a specific, time-bound conversation ("20 minutes to compare notes on [specific topic]")
• Easy out: "If this isn't a priority right now, no worries -- happy to reconnect when timing is better"

Rules:

• Under 100 words
• Be direct but respectful
• Include a specific proposed time or scheduling link
• Make it easy to say yes OR no

Touch 6: LinkedIn Engagement (Day 15)

Purpose: Stay visible without being pushy. Engage authentically.

Structure:

• Comment thoughtfully on one of their recent LinkedIn posts (if available)
• OR share a post tagging their company about a relevant industry topic
• OR react to their company's content
• This is a "warm presence" touch, not a direct outreach

Touch 7: Break-Up Email (Day 20)

Purpose: Final touch that often generates the highest response rate. Give them an easy way back in.

Structure:

• Subject line: Simple, personal (2 variants). Examples: "Should I close the loop?" / "[First name] -- one last thought"
• Tone: Genuinely gracious, zero pressure
• Brief summary of what you've shared (one sentence)
• Acknowledge timing may not be right
• Leave the door open: "If [pain point] becomes a priority, I'm an easy person to reach"
• Optional: Share one final compelling data point or insight

Rules:

• Under 80 words
• Must feel like a real human closing out, not a guilt trip
• No "I've tried reaching you X times"
• End on a positive, forward-looking note

Step 5: Quality Checks

Before delivering the sequence, verify:

1. Personalization audit: Every touch references something specific to this prospect. Remove any line that could apply to any company in the industry.
2. Tone check: Read each email aloud. Does it sound like a knowledgeable peer, or a salesperson? Revise if salesy.
3. Length check: No email exceeds its word limit.
4. Subject line check: No spam trigger words (free, guarantee, limited time, act now). No ALL CAPS. No excessive punctuation.
5. CTA progression: CTAs escalate naturally from soft to direct across the sequence.
6. Factual accuracy: Every referenced fact (trial, news, publication) is real and correctly attributed.
7. Compliance: No misleading claims about Talosix capabilities. No disparagement of competitors by name in outreach.

Step 6: Output Format

Deliver the complete sequence in this format:

# Outreach Sequence: [Prospect Name] at [Company]

## Prospect Context
- **Name**: [Full name]
- **Title**: [Current title]
- **Company**: [Company name]
- **ICP Score**: [If available from prior research]
- **Key Signal**: [Primary buying signal driving this outreach]
- **Core Pain Hypothesis**: [The challenge this sequence addresses]
- **Personalization Anchors**: [List of specific facts used for personalization]

## Sequence Overview
| Touch | Day | Channel | Purpose | CTA Level |
|-------|-----|---------|---------|-----------|
| 1 | 1 | Email | Insight-led open | Soft |
| 2 | 3 | LinkedIn | Connection request | None |
| 3 | 5 | Email | Value add follow-up | Medium |
| 4 | 8 | LinkedIn/Email | Thought leadership share | Soft |
| 5 | 12 | Email | Direct meeting request | Direct |
| 6 | 15 | LinkedIn | Engagement/visibility | None |
| 7 | 20 | Email | Gracious close | Open door |

## Touch 1: Initial Email (Day 1)
**Subject A**: [subject line]
**Subject B**: [subject line]

[Full email body]

---

## Touch 2: LinkedIn Connection (Day 3)
[Connection note, under 300 characters]

---

[...continue for all touches...]

## Sequence Notes
- **If they respond positively at any touch**: Stop the sequence, transition to live conversation.
- **If they respond with objection**: Address it directly, do not continue automated sequence.
- **If they connect on LinkedIn but don't respond to email**: Shift primary channel to LinkedIn.
- **Recommended follow-up after sequence**: Re-engage in 90 days with new trigger event.

Talosix Messaging Guidelines

When referencing Talosix, adhere to these principles:

• Lead with outcomes, not features: "Reduce study build time by 60%" not "Our drag-and-drop form builder"
• Use peer language: "Companies like [similar org] have found..." not "Our customers say..."
• Clinical credibility: Reference specific regulatory standards (21 CFR Part 11, ICH E6 R2) to demonstrate domain expertise
• Differentiation themes: Modern cloud-native architecture, rapid study configuration, purpose-built for clinical trials, transparent pricing
• Avoid: Feature dump, competitive bashing, urgency tactics, generic value propositions